BMY
Bristol-Myers Squibb Company
62.90$
+2.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -10.5% | -33.3% | -17.9% | +140.4% | -20.6% | -56.0% | +100.5% | +61.1% | -68.7% | -44.1% | +207.3% | – | |
| – | +1.2% | +2.8% | +2.5% | -0.2% | -27.5% | -46.2% | -0.1% | +0.0% | -3.4% | -39.2% | +0.0% | – | |
| – | -3.8% | +4.7% | -6.0% | +3.2% | -7.0% | +20.0% | -4.9% | +1.5% | -4.3% | +9.8% | -7.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +193.8% | -76.8% | -1,297.5% | – | -25.2% | -246.6% | – | +20,266.7% | -154.1% | – | – | – | |
| – | -3.5% | -13.9% | -7.7% | +23.7% | +16.7% | -31.2% | +38.8% | -11.4% | +15.6% | -6.2% | -12.1% | – | |
| – | +228.3% | +1,357.5% | -93.3% | -83.4% | -10.5% | +154.6% | -5.2% | +259.8% | -14.3% | -91.0% | +1,132.1% | – | |
| – | -2.6% | +4.5% | +0.4% | -0.1% | +0.2% | +3.3% | +0.3% | +0.1% | -0.1% | +1.7% | +0.3% | – | |
| – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -84.7% | – | -259.0% | -61.7% | +2,013.4% | -96.2% | +654.2% | – | |
| – | – | +1,414.4% | -127.5% | -4.3% | -57.4% | -39.5% | +84.9% | -18.8% | +304.6% | -74.1% | +68.6% | – | |
| – | – | -155.3% | – | – | +53.7% | -78.5% | +228.8% | +79.4% | -276.8% | – | – | – | |
| – | -11.0% | -35.0% | -19.1% | +155.2% | -22.9% | -58.3% | +109.9% | +68.5% | -73.2% | -52.8% | +307.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.